Addex Therapeutics (ADXN) EBT (2022 - 2025)
Historic EBT for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to -$2.0 million.
- Addex Therapeutics' EBT fell 1182.67% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.3 million, marking a year-over-year decrease of 4026.93%. This contributed to the annual value of -$5.6 million for FY2024, which is 10046.34% down from last year.
- According to the latest figures from Q3 2025, Addex Therapeutics' EBT is -$2.0 million, which was down 1182.67% from -$2.4 million recorded in Q2 2025.
- Addex Therapeutics' 5-year EBT high stood at $6.6 million for Q4 2022, and its period low was -$7.5 million during Q2 2022.
- Moreover, its 4-year median value for EBT was -$1.6 million (2024), whereas its average is -$1.7 million.
- Per our database at Business Quant, Addex Therapeutics' EBT surged by 9365.62% in 2023 and then plummeted by 17779.3% in 2024.
- Over the past 4 years, Addex Therapeutics' EBT (Quarter) stood at $6.6 million in 2022, then plummeted by 115.36% to -$1.0 million in 2023, then crashed by 34.16% to -$1.4 million in 2024, then tumbled by 45.16% to -$2.0 million in 2025.
- Its EBT stands at -$2.0 million for Q3 2025, versus -$2.4 million for Q2 2025 and -$1.6 million for Q1 2025.